SPIMACO sells stake in EirGen Pharma for SAR 152.4 mln profit

06/05/2015 Argaam

Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has closed a deal to sell its 48.5 percent stake in the Irish company, Eirgen Pharma, to the US-based firm Opko Health in​ a deal worth $135 million ($506 million)​.

 

SPIMACO said in a statement to Tadawul that its share of the deal is $65.4 million (SAR 245.4 million), making a SAR 152.4 million in profit from the company, which it purchased in March 2012 for SAR 93 million.

 

The company said the deal will reflect in second quarter results. Part of the revenue generated will be used to finance a cancer treatment project, which will be announced later.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.